Inhibiting Disease-Associated Anaerobic Choline Metabolism by Human Gut Bacteria
ORMAN-DISSERTATION-2019.pdf (5.988Mb)(embargoed until: 2021-05-01)
MetadataShow full item record
CitationOrman, Marina. 2019. Inhibiting Disease-Associated Anaerobic Choline Metabolism by Human Gut Bacteria. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences.
AbstractThe anaerobic gut microbial pathway that converts choline into trimethylamine (TMA) is broadly linked to human disease. Here, we describe the discovery that betaine aldehyde inhibits TMA production from choline by human gut bacterial isolates and a complex gut community. The workflow we establish for identifying and characterizing betaine aldehyde provides a framework for developing additional inhibitors of gut microbial choline metabolism. We also describe further efforts towards discovering small molecule inhibitors of CutC-mediated choline cleavage. Overall, our results show that small molecules can interfere with choline metabolism by anaerobic gut microbes and sets the stage for more extensive efforts to discover novel potent inhibitors of this pathway.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:42029670
- FAS Theses and Dissertations